HOWL · Werewolf Therapeutics, Inc. · Executive Compensation
$0.93
+0.00 (+0.20%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jul 31, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We believe there is substantial doubt about our ability to continue as a going concern for at least twelve months from the date that these condensed consolidated financial statements are issued in this Quarterly Report. We are currently evaluating strategies to raise additional capital, however, there can be no assurances that we will be successful in mitigating the conditions which raise substantial doubt about our ability to continue as a going concern in the near term, if at all.”View the 10-Q filed Jul 31, 2026
Market Cap
$46.65M
Shares
48.60M
Volume · Oct 5
239.08K
Avg daily vol (3M)
6.73M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Daniel J. Hicklin | President and Chief Executive Officer | $2,545,599 |
| Randi Isaacs | Chief Medical Officer | $1,440,024 |
| Timothy W. Trost | Chief Financial Officer and Treasurer | $1,216,560 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Daniel J. Hicklin | President and Chief Executive Officer | $1,366,904 |
| Randi Isaacs | Chief Medical Officer | $855,765 |
| Timothy W. Trost | Chief Financial Officer and Treasurer | $815,585 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Daniel J. Hicklin | President and Chief Executive Officer | $2,474,896 |
| Randi Isaacs | Chief Medical Officer | $1,218,819 |
| Cynthia Seidel-Dugan | Chief Scientific Officer | $1,210,878 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Chulani Karunatilake | Chief Technology Officer | $3,863,682 |
| Daniel J. Hicklin | President and Chief Executive Officer | $2,462,548 |
| Timothy W. Trost | Chief Financial Officer | $2,090,049 |
| Randi Isaacs | Chief Medical Officer | $1,310,253 |
| Cynthia Seidel-Dugan | Chief Scientific Officer | $1,186,721 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Daniel J. Hicklin | President and Chief Executive Officer | $2,989,923 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Timothy W. Trost | Chief Financial Officer | Resigned | 2026-02-13 |
| Anil Singhal, Ph.D. | Class I director | Appointed | 2025-02-24 |
| Cynthia Seidel-Dugan, Ph.D. | Chief Scientific Officer | Retired | 2024-03-07 |
| Michael B. Atkins | director | Appointed | 2024-01-04 |